Delynov Chirurgie, Delynov M-TEER: stroke volume gain for atrial but not ventricular MR Transcatheter edge-to-edge mitral repair (M-TEER) is now a gold-standard procedure for treating secondary mitral regurgitation (MR). While stroke volume... Jan 1, 2026
Delynov Chirurgie, Delynov First case of Magnusiomyces clavatus endocarditis on a prosthetic valve Fungal infective endocarditis represents one of the most formidable complications of valvular surgery, characterised by extremely high mortality. This article examines the diagnostic challenges and therapeutic strategies for this severe clinical condition. Jan 1, 2026
Delynov Chirurgie, Delynov Valvular surgery: fees have fallen by 28% since 2015 In the United States, reimbursement for procedures by the Centers for Medicare & Medicaid Services (CMS) is based on the allocation of Relative Value Units (RVU) weighted by a factor. This system determines the compensation for medical acts according to the resources and expertise required. Jan 1, 2026
Delynov Chirurgie, Delynov Mitral Valve Repair: Surgical Challenges and the Key Role of Nursing Care Mitral valve pathologies, primarily encompassing mitral regurgitation and stenosis, remain a major cause of cardiovascular morbidity and mortality worldwide. Dec 31, 2025
Delynov Chirurgie, Delynov Mitral repair: adding tricuspid annuloplasty reduces leakage by 66% Tricuspid regurgitation (TR) frequently accompanies degenerative mitral regurgitation, systematically worsening the clinical prognosis of patients. While the observation is clear, the... Dec 30, 2025
Delynov Chirurgie, Delynov MitraClip G4: sustained technical success on non-central mitral regurgitation The management of severe primary mitral regurgitation (PMR) in high surgical risk patients now relies on transcatheter edge-to-edge repair (TMVR). Dec 30, 2025
Delynov Chirurgie, Delynov Triple valve surgery: an asset against retinal vein occlusion Sequential bilateral central retinal vein occlusion (CRVO) raises critical questions regarding the influence of systemic risk factors, particularly hemo... Dec 25, 2025
Delynov Chirurgie, Delynov Carillon Annuloplasty: The Coronary Sinus Advantage for Mitral Regurgitation Functional mitral regurgitation (FMR) affects 20 to 30% of patients with heart failure with reduced ejection fraction (HFrEF). This coaptation defect... Dec 23, 2025
Delynov Chirurgie, Delynov Mitral valve repair: the anterior leaflet as a reference for loops While surgical repair remains the gold standard for treating mitral regurgitation (MR), neochordal reconstruction using the loop technique offers a... Dec 22, 2025
Delynov Chirurgie, Delynov Mitral valve repair: robotic surgery reduces transfusions and ICU stay length The treatment of degenerative mitral regurgitation has radically evolved toward non-sternotomy approaches, yet the choice between classic anterolateral minithoracotomy and... Dec 22, 2025
Delynov Chirurgie, Delynov Tricuspid annuloplasty: the GLIDE score to predict technical success In the management of tricuspid regurgitation (TR), selecting candidates for transcatheter tricuspid valve annuloplasty (TTVA) remains a major clinical challenge. While the GLIDE score — eva... Dec 22, 2025
Delynov Chirurgie, Delynov MICS in Japan: 2022 national results confirm record safety Since the 2018 pricing shift and reimbursement for sternal preservation techniques, minimally invasive cardiac surgery (MICS) has seen rapid adoption in Japan. Dec 19, 2025